Joseph W. Graskemper
General Manager, Early Phase
Development & Manufacturing
Biogen
Gerald Artman
Director of CMC
Eradivir
Nicolas Mourier
Vice President, CMC
Altimmune
Roger Hanselmann
Senior Director, Process Chemistry
Ardelyx
Mathew Yanik
Senior Director, API Chemistry
Intercept Pharmaceuticals
Max Reeve
Executive Director,
CMC External Manufacturing & Supply
Arvinas
Arthur Kasson
Sales Manager
YMC America
Swati Aurora
Principal Scientist – Peptide
Eli Lilly and Company
Rosario LoBrutto
Vice President, Global Head of Technical Operations
Ironwood Pharmaceuticals
Scott Duncan
Dir. Drug Substance
Intuitive
Jackie O’Neil
Dir. CMC & Tech Ops
Newleos
Jennifer Albaneze-Walker
Head of API Development
Biogen
Stefan Loren
Managing Director Healthcare Investment Banking
Oppenheimer
Will Jackson
Principal Applications Scientist
YMC America
Deborah Minor
President/Owner
Drug Discovery Alliances
Jim Bruno
Owner
Biomedical Solutions LLC
Brian Eklov
Chief Executive Officer
Dipharma
Malken Bayrakdarian
VP of CMC
Sygnature Discovery
Martial Bertrand
Senior Director, Process Chemistry
Sygnature Discovery
Robert Geiger
Senior Director, API Chemistry
Lupin Manufacturing Solutions
Mimoun Ayoub
VP CMC
Corden Pharma
Keith Porter
Director, Business Development
Bachem
Pin-Nan Cheng
Sr. Dir, Drug Substance
Development,CMC
Altimmune
Shonna Scalfani
SVP, Head Global CMC
Amylyx
Rupesh Agarwal
Senior Data Scientist II
Novo Nordisk